Key facts
- This page summarizes Xiaofan Neo Zhang's Form 3 filing for NovaBridge Biosciences (NBP).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 21:40.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.
Footnote F2
Reported securities are represented by 380,000 ADSs.
SEC remarks
Exhibit List: Ex. 24.1 - Power of Attorney